Loading clinical trials...
Loading clinical trials...
This study is intended to define the PCM normal laboratory range.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Entegrion, Inc.
NCT05156983 · Coagulation Disorder
NCT06403163 · Transfusion Reaction, Transfusion Related Complication, and more
NCT07024160 · Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
NCT00178594 · Blood Coagulation Disorders, Inherited, Thrombotic Disorder
NCT05305612 · Mitral Regurgitation, Atrial Fibrillation, and more
Washington University in St. Louis
St Louis, Missouri
Thomas Jefferson University
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions